Patents by Inventor Swen Wolfram

Swen Wolfram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating conditions associated with increased eotaxin with 25-hydroxyvitamin D3
    Patent number: 10357501
    Abstract: Methods for treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol) are provided. Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: July 23, 2019
    Assignee: DSM IP ASSETS B.V.
    Inventors: Stephanie Krammer-Lukas, Elisabeth Stoecklin, Joseph Schwager, Swen Wolfram
  • TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3
    Publication number: 20170106005
    Abstract: Methods for treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol) are provided. Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
    Type: Application
    Filed: December 28, 2016
    Publication date: April 20, 2017
    Inventors: Stephanie KRAMMER-LUKAS, Elisabeth STOECKLIN, Joseph SCHWAGER, Swen WOLFRAM
  • COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3
    Publication number: 20160324877
    Abstract: We disclose compositions comprising Vitamin D (cholecalciferol and /or ergocalciferol) and 25-OH D3 (calcifediol), and use of those compositions to affect at least concentration, bioavailability, metabolism, or efficacy of vitamin D in a human. Forms and dosages of the composition, as well as processes for manufacturing a spray-dried formulation, are also disclosed.
    Type: Application
    Filed: July 20, 2016
    Publication date: November 10, 2016
    Inventors: Neil Robert BUCK, Wouter CLAERHOUT, Bruno H. LEUENBERGER, Elisabeth STOECKLIN, Kai URBAN, Swen WOLFRAM
  • USE OF 25-HYDROXY-VITAMIN D3 TO AFFECT HUMAN MUSCLE PHYSIOLOGY
    Publication number: 20160263128
    Abstract: We disclose the use of 25-OH D3 (calcifediol) to increase muscle strength, muscle function, or both. Vitamin D3 (cholecalciferol) may optionally be used together with 25-OH D3. Forms and dosages of a pharmaceutical composition, as well as processes for manufacturing medicaments, are also disclosed.
    Type: Application
    Filed: May 26, 2016
    Publication date: September 15, 2016
    Inventors: Neil Robert BUCK, Wouter CLAERHOUT, Bruno H. LEUENBERGER, Elisabeth STOECKLIN, Kai URBAN, Swen WOLFRAM
  • Trigonelline as a muscle stimulant
    Patent number: 9241938
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: January 26, 2016
    Assignee: DSM IP ASSETS B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • TRIGONELLINE AS A MUSCLE STIMULANT
    Publication number: 20150079206
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: November 20, 2014
    Publication date: March 19, 2015
    Inventors: Angelika FRIEDEL, Karin KURATLI, Christof WEHRLI, Karin WERTZ, Swen WOLFRAM, Ying WANG-SCHMIDT
  • Niacin and/or trigonelline as a muscle stimulant
    Patent number: 8772230
    Abstract: This invention relates to the use of niacin and/or trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: July 8, 2014
    Assignee: DSM IP Assets B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3
    Publication number: 20130252927
    Abstract: The present invention relates to treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol). Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
    Type: Application
    Filed: December 5, 2011
    Publication date: September 26, 2013
    Applicant: DSM IP ASSETS, B.V.
    Inventors: Stephanie Krammer-Lukas, Elisabeth Stoecklin, Joseph Schwager, Swen Wolfram
  • USE OF 25-HYDROXY-VITAMIN D3 TO AFFECT HUMAN MUSCLE PHYSIOLOGY
    Publication number: 20130150598
    Abstract: The use of 25-OH D3 (calcifediol) to increase muscle strength, muscle function, or both is provided. Vitamin D3 (cholecalciferol) may optionally be used together with 25-OH D3. Forms and dosages of a pharmaceutical composition, as well as processes for manufacturing medicaments, are also disclosed.
    Type: Application
    Filed: May 9, 2012
    Publication date: June 13, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: Neil Robert BUCK, Wouter Claerhout, Bruno H. Leuenberger, Elisabeth Stoecklin, Kai Urban, Swen Wolfram
  • TRIGONELLINE AS A MUSCLE STIMULANT
    Publication number: 20130018076
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: September 7, 2012
    Publication date: January 17, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: Angelika FRIEDEL, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Trigonelline as a muscle stimulant
    Patent number: 8323707
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: December 4, 2012
    Assignee: DSM IP Assets B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Use of phthalide derivatives for the treatment of type 2 diabetes mellitus
    Patent number: 8242168
    Abstract: The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: August 14, 2012
    Assignee: DSM IP Assets B.V.
    Inventors: Daniel D'Orazio, Antoine De Saizieu, Goede Schueler, Daniel Raederstorff, Sandra Renata Teixeira, Ying Wang Schmidt, Peter Weber, Swen Wolfram
  • COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3
    Publication number: 20120196057
    Abstract: We disclose compositions comprising Vitamin D (cholecalciferol and/or ergocalciferol) and 25-OH D3 (calcifediol), and use of those compositions to affect at least concentration, bioavailability, metabolism, or efficacy of vitamin D in a human. Forms and dosages of the composition, as well as processes for manufacturing a spray-dried formulation, are also disclosed.
    Type: Application
    Filed: April 13, 2012
    Publication date: August 2, 2012
    Inventors: Neil Robert Buck, Wouter Claerhout, Bruno H. Leuenberger, Elisabeth Stoecklin, Kai Urban, Swen Wolfram
  • NIACIN AND/OR TRIGONELLINE AS A MUSCLE STIMULANT
    Publication number: 20120190617
    Abstract: This invention relates to the use of niacin and/or trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: June 10, 2010
    Publication date: July 26, 2012
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • Compositions comprising epigallocatechin gallate and protein hydrolysate
    Patent number: 8129337
    Abstract: The present invention describes a composition comprising EGCG and a protein hydrolysate.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: March 6, 2012
    Assignee: DSM IP Assets B.V.
    Inventor: Swen Wolfram
  • CAJANUS EXTRACTS AND GLUCOSAMINE FOR INFLAMMATORY DISORDERS
    Publication number: 20110300240
    Abstract: The present invention relates to novel compositions comprising Cajanus and glucosamine as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
    Type: Application
    Filed: February 19, 2010
    Publication date: December 8, 2011
    Inventors: Daniel Raederstorff, Nathalie Richard, Joseph Schwager, Christof Wehrli, Swen Wolfram
  • ROSEHIP POWDER HAVING SMALL PARTICLE SIZE
    Publication number: 20110262612
    Abstract: Rosehip powder has been finely ground such that it contains essentially no particles larger than 600 um when measured by laser diffraction. In one aspect of the invention (claim 1) 50% of the particles have a size of 100-150 microns. The fine powder can be used in foodstuffs which are subsequently high pressure homogenized, such as smoothies and milk based beverages. Additionally, the fine powder can be added to yoghurts and other juices while retaining acceptable sensory characteristics.
    Type: Application
    Filed: April 17, 2009
    Publication date: October 27, 2011
    Inventors: Nicolle Götz, Ullrich Kranzer, Swen Wolfram
  • TRIGONELLINE AS A MUSCLE STIMULANT
    Publication number: 20110142974
    Abstract: This invention relates to the use of trigonelline compounds to increase muscle weight during periods of activity or to inhibit muscle loss during periods of inactivity.
    Type: Application
    Filed: December 3, 2010
    Publication date: June 16, 2011
    Applicant: DSM IP ASSETS B.V.
    Inventors: Angelika Friedel, Karin Kuratli, Christof Wehrli, Karin Wertz, Swen Wolfram, Ying Wang-Schmidt
  • TREATING HYPERTENSION WITH 25-HYDROXYVITAMIN D3
    Publication number: 20110118218
    Abstract: We disclose the use of optionally in combination with vitamin D3 (cholecalciferol), 25-hydroxyvitamin D3 (cal-cifediol), to treat hypertension. Forms and dosages of a pharmaceutical composition, as well as processes for manufacturing medicaments, are also disclosed.
    Type: Application
    Filed: February 12, 2009
    Publication date: May 19, 2011
    Inventors: Neil Robert Buck, Wouter Claerhout, Bruno H. Leuenberger, Elisabeth Stoecklin, Kai Urban, Swen Wolfram
  • COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3
    Publication number: 20110052707
    Abstract: We disclose compositions comprising Vitamin D (cholecalciferol and/or ergocalciferol) and 25-OH D3 (calcifediol), and use of those compositions to affect at least concentration, bioavailability, metabolism, or efficacy of vitamin D in a human. Forms and dosages of the composition, as well as processes for manufacturing a spray-dried formulation, are also disclosed.
    Type: Application
    Filed: February 12, 2008
    Publication date: March 3, 2011
    Inventors: Neil Robert Buck, Wouter Claerhout, Bruno H. Leuenberger, Elisabeth Stoecklin, Kai Urban, Swen Wolfram